- Our Company
- News & Events
- Contact Us
Check out this Channel NewsAsia article featuring our CEO, Simranjit Singh, sharing his views on how liquid biopsies may provide a safer and more efficient alternative to invasive interventional procedures and reduce the need for cancer patients to be hospitalised or have multiple visits to the clinic. The diagnosis and timely treatment of cancer patients should not be compromised during this pandemic.
Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at email@example.com or contact us on WhatsApp: +65 8940 0360.
Guardant360®. Test. Take Action.